These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1337 related articles for article (PubMed ID: 22980982)

  • 1. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.
    Talchai C; Xuan S; Lin HV; Sussel L; Accili D
    Cell; 2012 Sep; 150(6):1223-34. PubMed ID: 22980982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of FOXO1 in β-cell failure and type 2 diabetes mellitus.
    Kitamura T
    Nat Rev Endocrinol; 2013 Oct; 9(10):615-23. PubMed ID: 23959366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitor-mediated beta-cell dedifferentiation model reveals distinct roles for FoxO1 in glucagon repression and insulin maturation.
    Casteels T; Zhang Y; Frogne T; Sturtzel C; Lardeau CH; Sen I; Liu X; Hong S; Pauler FM; Penz T; Brandstetter M; Barbieux C; Berishvili E; Heuser T; Bock C; Riedel CG; Meyer D; Distel M; Hecksher-Sørensen J; Li J; Kubicek S
    Mol Metab; 2021 Dec; 54():101329. PubMed ID: 34454092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function.
    Talchai SC; Accili D
    Diabetes; 2015 Aug; 64(8):2868-79. PubMed ID: 25784544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes.
    Cinti F; Bouchi R; Kim-Muller JY; Ohmura Y; Sandoval PR; Masini M; Marselli L; Suleiman M; Ratner LE; Marchetti P; Accili D
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1044-54. PubMed ID: 26713822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the anti-β-cell dedifferentiation mechanism of a modified Da Chaihu Decoction by an integrative approach of network pharmacology and experimental verification.
    Chen H; Guo J; Cai Y; Zhang C; Wei F; Sun H; Cheng C; Liu W; He Z
    J Ethnopharmacol; 2024 Mar; 321():117481. PubMed ID: 38007164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-cell dedifferentiation and type 2 diabetes.
    Dor Y; Glaser B
    N Engl J Med; 2013 Feb; 368(6):572-3. PubMed ID: 23388011
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of α cell-restricted Gc in dedifferentiating β cells contributes to stress-induced β-cell dysfunction.
    Kuo T; Damle M; González BJ; Egli D; Lazar MA; Accili D
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure.
    Fan J; Du W; Kim-Muller JY; Son J; Kuo T; Larrea D; Garcia C; Kitamoto T; Kraakman MJ; Owusu-Ansah E; Cirulli V; Accili D
    Mol Metab; 2020 Apr; 34():97-111. PubMed ID: 32180563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice.
    Kim-Muller JY; Zhao S; Srivastava S; Mugabo Y; Noh HL; Kim YR; Madiraju SR; Ferrante AW; Skolnik EY; Prentki M; Accili D
    Cell Metab; 2014 Oct; 20(4):593-602. PubMed ID: 25264246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure.
    Kluth O; Mirhashemi F; Scherneck S; Kaiser D; Kluge R; Neschen S; Joost HG; Schürmann A
    Diabetologia; 2011 Mar; 54(3):605-16. PubMed ID: 21107520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxO1 Deacetylation Decreases Fatty Acid Oxidation in β-Cells and Sustains Insulin Secretion in Diabetes.
    Kim-Muller JY; Kim YJ; Fan J; Zhao S; Banks AS; Prentki M; Accili D
    J Biol Chem; 2016 May; 291(19):10162-72. PubMed ID: 26984405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon receptor blockage inhibits β-cell dedifferentiation through FoxO1.
    Wang K; Cui X; Li F; Xia L; Wei T; Liu J; Fu W; Yang J; Hong T; Wei R
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E97-E113. PubMed ID: 36383639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers.
    Chera S; Baronnier D; Ghila L; Cigliola V; Jensen JN; Gu G; Furuyama K; Thorel F; Gribble FM; Reimann F; Herrera PL
    Nature; 2014 Oct; 514(7523):503-7. PubMed ID: 25141178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxO1 as a double-edged sword in the pancreas: analysis of pancreas- and β-cell-specific FoxO1 knockout mice.
    Kobayashi M; Kikuchi O; Sasaki T; Kim HJ; Yokota-Hashimoto H; Lee YS; Amano K; Kitazumi T; Susanti VY; Kitamura YI; Kitamura T
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E603-13. PubMed ID: 22215655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Acsl4 in absence of mTORC2/Rictor drove β-cell dedifferentiation via inhibiting FoxO1 and promoting ROS production.
    Cui C; Li T; Xie Y; Yang J; Fu C; Qiu Y; Shen L; Ni Q; Wang Q; Nie A; Ning G; Wang W; Gu Y
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166261. PubMed ID: 34455055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell dedifferentiation is a pathologic mechanism of long-standing progression of type 2 diabetes.
    Amo-Shiinoki K; Tanabe K; Hoshii Y; Matsui H; Harano R; Fukuda T; Takeuchi T; Bouchi R; Takagi T; Hatanaka M; Takeda K; Okuya S; Nishimura W; Kudo A; Tanaka S; Tanabe M; Akashi T; Yamada T; Ogawa Y; Ikeda E; Nagano H; Tanizawa Y
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33427207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Sirt3 contributes to β-cell dedifferentiation via FoxO1 in type 2 diabetic mellitus.
    Nie Y; Zhang Y; Liu S; Xu Z; Xia C; Du L; Yin X; Wang J
    Acta Diabetol; 2024 Apr; 61(4):485-494. PubMed ID: 38150004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-cell dedifferentiation in diabetes is important, but what is it?
    Weir GC; Aguayo-Mazzucato C; Bonner-Weir S
    Islets; 2013; 5(5):233-7. PubMed ID: 24356710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes.
    Moin ASM; Butler AE
    Curr Diab Rep; 2019 Aug; 19(9):83. PubMed ID: 31401713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.